Author:
Sarmiento M,Salinas J,Rojas P,Gutierrez C,Vidal M,Jara V,Garcia MJ,Campbell MJ,Flores Y,Sandoval V,Vergara M,Palacios F,Ocqueteau M
Funder
Pontificia Universidad Católica de Chile
Reference21 articles.
1. Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European group for blood and marrow transplantation;Mohty;Bone Marrow Transpl,2014
2. et al. The biology and clinical uses of blood stem cells;ToL;Blood,1997
3. Low-Dose Cyclophosphamide versus intermediate-high-dose cyclophosphamide versus granulocyte colony-stimulating factor alone for stem cell mobilization in multiple myeloma in the era of novel agents: a multicenter retrospective study;Zannetti;Transpl Cell Ther,2021
4. Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma;Hartmann;Cochrane Database Syst Rev,2015
5. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist;Liles;Transfusion,2005